Fair Value Measurement and Disclosures - Schedule of the Valuation of the Company's Investments in the Fair Value Hierarchy Levels (Parenthetical) (Detail) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | $ 2,101,797 | $ 1,575,363 | ||||||||||||
| Investments Measured at NAV [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | $ 754,696 | [1],[2],[3] | $ 662,962 | [4],[5] | ||||||||||
| Investment, Type [Extensible Enumeration] | Investment in Preferred Units of Liability Company [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||
| Unfunded commitments | $ 64,869 | $ 85,472 | ||||||||||||
| Investments Measured at NAV [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | 670,208 | 576,407 | ||||||||||||
| Series I [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | 608,376 | 468,403 | ||||||||||||
| Series I [Member] | Investments Measured at NAV [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | $ 218,450 | [1],[2],[3] | $ 197,120 | [4],[5] | ||||||||||
| Investment, Type [Extensible Enumeration] | Investment in Preferred Units of Liability Company [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||
| Unfunded commitments | $ 18,777 | $ 25,414 | ||||||||||||
| Series I [Member] | Investments Measured at NAV [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | 193,995 | 171,384 | ||||||||||||
| Series II [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | 1,493,421 | 1,106,960 | ||||||||||||
| Series II [Member] | Investments Measured at NAV [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | $ 536,246 | [1],[2],[3] | $ 465,842 | [4],[5] | ||||||||||
| Investment, Type [Extensible Enumeration] | Investment in Preferred Units of Liability Company [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||
| Unfunded commitments | $ 46,092 | $ 60,058 | ||||||||||||
| Series II [Member] | Investments Measured at NAV [Member] | Investment in Preferred Units of Liability Company [Member] | ||||||||||||||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||||||||||||||
| Fair Value | $ 476,213 | $ 405,023 | ||||||||||||
| ||||||||||||||